Magnesium Imbalance Has Significant Neurological Manifestations
Magnesium electrolyte imbalance is not classified as a primary "neurological condition" per se, but it produces substantial neurological symptoms and complications that require urgent recognition and treatment. Magnesium abnormalities—both hypomagnesemia and hypermagnesemia—are metabolic/electrolyte disorders that manifest with prominent neurological features affecting morbidity and mortality 1.
Why This Distinction Matters Clinically
Magnesium plays a critical role in stabilizing excitable membranes and is essential for sodium, potassium, and calcium movement across cells 1. When magnesium levels are abnormal, the neurological manifestations are often the presenting and most dangerous symptoms, but the underlying problem is metabolic rather than a primary neurological disease process.
Hypermagnesemia: Neurological Toxicity
Hypermagnesemia (>2.2 mEq/L) produces direct neurological symptoms including 1:
- Muscular weakness and paralysis
- Ataxia
- Drowsiness and confusion
- Depressed level of consciousness
- At extremely high levels: bradycardia, hypoventilation, and cardiorespiratory arrest
The neurological symptoms result from magnesium's effects on neuromuscular transmission and membrane excitability 2. These are metabolic complications with neurological expression.
Hypomagnesemia: Neurological Hyperexcitability
Hypomagnesemia (<1.3 mEq/L) causes neurological symptoms through membrane instability 3:
- Confusion and hallucinations
- Irritability
- Nystagmus
- Seizures (can be the presenting symptom)
- Contractures and severe pain
- Tetany
The 2018 ESMO guidelines specifically identify hypomagnesemia as causing "confusion and hallucinations" along with "irritability, nystagmus, seizures, contractures and severe pain" 3. A 2024 case report demonstrated severe neurological deficits including seizures, tremors, visual hallucinations, diplopia, personality changes, and ataxia from profound hypomagnesemia 4.
Clinical Classification Framework
Think of magnesium imbalance as:
- Primary problem: Metabolic/electrolyte disorder
- Clinical presentation: Often dominated by neurological symptoms
- Management approach: Treat the electrolyte abnormality to resolve neurological manifestations
This is analogous to how hypoglycemia is an endocrine/metabolic problem that presents with neurological symptoms (confusion, seizures, coma) but isn't classified as a neurological disease.
Critical Clinical Pitfalls
Common mistake: Attributing neurological symptoms to primary neurological disease and missing the underlying magnesium abnormality 5. An 82-year-old woman presented with nystagmus, mydriasis, encephalopathy, and seizures—all from PPI-induced hypomagnesemia that resolved completely with magnesium supplementation 5.
Key point: Magnesium levels should be checked in any patient presenting with:
- Unexplained encephalopathy
- New-onset seizures
- Atypical neurological symptoms
- Cardiac arrhythmias (especially torsades de pointes)
The 2017 AHA guidelines emphasize that hypomagnesemia can produce polymorphic ventricular tachycardia and recommend IV magnesium 1-2 g for cardiotoxicity and cardiac arrest 1.
Bidirectional Relationship
Recent evidence highlights that neurological injury itself can cause electrolyte disturbances, including magnesium abnormalities 6. This creates a reciprocal relationship where:
- Magnesium imbalance causes neurological symptoms
- Neurological injury (TBI, stroke, status epilepticus) can cause magnesium disturbances
- The combination worsens outcomes
Bottom line: While magnesium imbalance produces prominent neurological manifestations that significantly impact morbidity and mortality, it remains fundamentally a metabolic/electrolyte disorder rather than a primary neurological condition. Recognition is critical because treatment of the electrolyte abnormality typically resolves the neurological symptoms completely 3, 4, 5.